InvestorsHub Logo
Followers 88
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: subslover post# 43273

Monday, 10/18/2021 12:17:59 PM

Monday, October 18, 2021 12:17:59 PM

Post# of 65501

“As we advance our cellular therapeutic products, the need for flexibility and manufacturing has become more and more apparent. By controlling our own manufacturing, we believe the Company is in a significantly better position to advance its objectives and reduce costs of production” said Timothy Dixon, President and CEO of Therapeutic Solutions International and Chairman of Allogen Biologics. “Dr. Ichim is one of the most accomplish developers of cellular therapies in regenerative medicine and immunology and we are honored for him to lead Allogen Biologics.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News